Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Plos One|December 3, 2020
Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell functionYun Wang, Kelvin Zhang, Peter Georgiev, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Glutamine-Dependent Biosynthetic Pathways Fuel Autoreactive T and B Cells in Foxp3 Deficiency-mediated DiseaseMohammad Adeel Zafar, Charlotte Nicole Hill Machado, Jyotirmaya Behera, et al.
Elife|July 8, 2026
Depletion of extracellular asparagine impairs self-reactive T cells and ameliorates autoimmunity in a murine model of multiple sclerosisPeter Georgiev, Sheila Johnson, Kiran Kurmi, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Depletion of extracellular asparagine impairs self-reactive T cells and ameliorates autoimmunity in a murine model of multiple sclerosisPeter Georgiev, Sheila Johnson, Kiran Kurmi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2012
IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapyErica G Schmitt, Dipica Haribhai, Jason B Williams, et al.
Cancer Immunology Research|February 21, 2020
Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell CarcinomaHandan Xiang, Carlo P Ramil, Josephine Hai, et al.
Cancer Research|June 15, 2017
Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory CellsSelvakumar Sukumar, Douglas C Wilson, Ying Yu, et al.
Cell Chemical Biology|September 16, 2023
Metabolic modulation of mitochondrial mass during CD4<sup>+</sup> T cell activationKiran Kurmi, Dan Liang, Robert van de Ven, et al.
Cancer Immunology Research|August 26, 2024
Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor ImmunityPeter Georgiev, SeongJun Han, Amy Y Huang, et al.
Oncoimmunology|April 2, 2021
Combination of EP<sub>4</sub> antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cellsYun Wang, Long Cui, Peter Georgiev, et al.
Pageof 3